I am delighted to be named the new editor in chief for Frontiers in Neuroendocrinology (FIN). I first want to extend a warm congratulations and thank you to Drs. Jon Levine and Jacques Balthazart for their incredible service to the journal for the last 12 and 10 years respectively. Under their combined stewardship the legacy of FIN has grown to become a leading journal in the field of neuroendocrinology for comprehensive reviews. The 2015 impact factor for FIN is 8.852 and is ranked by Journal Citation Reports in quartile 1 for both Endocrinology and Metabolism (8/131) and Neuroscience (15/256). While many do not put much stock in impact factor this certainly bodes well for the future of FIN. As others have done (Blaustein, 2012), I urge those in the community to put more emphasis on the number of citations per paper/review rather than impact factor of a certain journal. I have been in the field of Neuroendocrinology since I started my graduate career in 1989. I obtained my graduate training with Drs. Doreen Kimura, Martin Kavaliers and Peter Ossenkopp at the University of Western Ontario and continued with my postdoctoral work under the supervision of Dr. Bruce McEwen at the Rockefeller University. It was a formidable upbringing with my ‘‘neurotree” ancestors ranging from Sigmond Freud, Donald Hebb and Wilder Penfield. I am very grateful to my past and present mentors as they have taught me and continue to teach me a lot. My research interests lie broadly in understanding how sex and stress hormones influence brain health and disease in both females and males. With my appointment, we made some modifications to the journal. We re-branded the journal to give it a fresh, contemporary look starting with the cover of the journal has been redesigned from a particular mustard colour to a more serene colour headlined by the abbreviation of FIN instead of the longer Frontiers in Neuroendocrinology. This has several advantages perhaps the primary advantage to distinguish FIN from the Frontiers Media open access journals. While FIN is a subscription journal, as always, it is possible to make your paper open access in a variety of formats via using either an online repository (often available at your own institution) or via the open access pay system within Elsevier depending on the mandate from a particular funding agency. We also updated and expanded the Aims and Scope of the journal to include areas such as neuroimmune interactions, interactions with the gut microbiota and clinical considerations of neuroendocrine mechanisms within disease. One important consideration for any submission to FIN, be it a review or commentary, is that I will be asking authors to explicitly identify whether the cited data was conducted in males or females. Too often in the literature the reader is not informed of the sex of subjects from which specific data and theories may have been

中文翻译：

---

一个新的开始

我很高兴被任命为神经内分泌学前沿 (FIN) 的新主编。我首先要表示热烈的祝贺，并感谢 Drs。Jon Levine 和 Jacques Balthazart 在过去的 12 年和 10 年中分别为该杂志提供了令人难以置信的服务。在他们的共同管理下，FIN 的遗产已发展成为神经内分泌学领域的综合评论领先期刊。FIN 的 2015 年影响因子为 8.852，在内分泌学和代谢学 (8/131) 和神经科学 (15/256) 的期刊引证报告中排名第一。虽然许多人在影响因子方面没有太多存量，但这对于 FIN 的未来无疑是个好兆头。正如其他人所做的那样（Blaustein，2012），我敦促社区中的人更加重视每篇论文/评论的引用次数，而不是某个期刊的影响因子。自 1989 年开始我的研究生生涯以来，我一直在神经内分泌学领域工作。我在 Drs 那里获得了研究生培训。Doreen Kimura、Martin Kavaliers 和 Peter Ossenkopp 在西安大略大学，并在洛克菲勒大学的 Bruce McEwen 博士的指导下继续我的博士后工作。我的“神经树”祖先包括西格蒙德·弗洛伊德、唐纳德·赫布和怀尔德·彭菲尔德，这是一种令人生畏的成长经历。我非常感谢我过去和现在的导师，因为他们教会了我并将继续教会我很多东西。我的研究兴趣广泛地在于了解性和压力荷尔蒙如何影响女性和男性的大脑健康和疾病。在我的任命下，我们对期刊进行了一些修改。我们重新命名了该期刊，使其具有新鲜、现代的外观，从该期刊的封面开始从特定的芥末色重新设计为更宁静的颜色，标题为 FIN 的缩写，而不是更长的神经内分泌学前沿。这有几个优点，也许是将 FIN 与 Frontiers Media 开放获取期刊区分开来的主要优势。虽然 FIN 是一种订阅期刊，但与往常一样，可以通过使用在线存储库（通常在您自己的机构提供）或通过爱思唯尔内部的开放获取付费系统，使您的论文以各种格式开放获取，具体取决于来自特定资助机构的授权。我们还更新并扩展了期刊的目标和范围，以包括神经免疫相互作用、与肠道微生物群的相互作用以及疾病中神经内分泌机制的临床考虑等领域。任何提交给 FIN 的重要考虑因素，无论是评论还是评论，是我将要求作者明确确定引用的数据是针对男性还是女性进行的。在文献中，读者常常没有被告知具体数据和理论可能来自的主题的性别 是我将要求作者明确指出引用的数据是在男性还是女性中进行的。在文献中，读者常常没有被告知具体数据和理论可能来自的主题的性别 是我将要求作者明确指出引用的数据是在男性还是女性中进行的。在文献中，读者常常没有被告知具体数据和理论可能来自的主题的性别